Skip to main content
. 2023 Oct-Dec;17(4):175–177. doi: 10.5005/jp-journals-10078-1420

Table 2:

The 6-month success in the treated and fellow eye

Success Failure
SLT treated eye 37 (48.7%) 39 (51.3%)
SLT fellow eye 28 (36.8%) 48 (63.2%)